Who we are

Ausia BioTech was founded in 1993 to offer comprehensive sterile manufacturing solutions and customized support services to meet specific client requirements in the pharmaceutical industry. We are a contract manufacturing organization that specializes in aseptic manufacturing of parenterals.

Our Mission

Provide quality product to advance patient care.

Corporate Principle

Quality First.


  • Shaofeng Huang, Chairman of the Board
  • Fuchun Jiang, General Manager
  • Jianmin Tian, Executive Vice President
  • Ya Feng, Vice President, Quality
  • Zhenhua Zheng, Vice President, Production
  • Quanhua Xu, Chief Engineer (R&D)

Key Competitive Advantages:

  • emphasis on continuous improvement of quality management system
  • CMO model that focuses on scale, flexibility, and cost control.
  • Experience and expertise in aseptic processing
  • Vibrant company culture that represents our passion for the business

Quick Facts




Hangzhou, China


About 400

Number of CMO products


Product portfolios

Lyophilized Powder for injections, Liquid fills.

Annual Production Capacity

200 million Vials

Last year’s (2011) CMO sales volume

120 million vials

Financial Highlights from 2011

Annual sales revenue

grow 5% to 14 million USD

Profit margin

grow 6% to 39.4%

Net cash flow

7.7 million USD

Capital spent in facility expansion

6 million USD

Facility Overview

Area of the factory compound


Area of production spaces


Area of warehouse


Number of Lyophilizers

18 Shelves spaces range from 20m2 to 45m2

Number of Filling lines

8 high-speed linear washing/drying/filling lines

Connect with us
© Copyright 2012, AusiaBio Technoleghy, All rights reserved.   www.ausiabio.com   www.ausia.net   浙ICP备12005543号